XLH
  XLH Network

Home About XLH Contact PHEX Modeling Advances in XLH knowledge

 

 

 

XLH Research

If you do not find the information you are looking for on, please contact us : pol.harvengt@gmail.com, maybe we can help !

Copyright (C) 2005 by Pol Harvengt.

Recombinant Phex protein

Enobia Pharma is developping an ERT (Enzyme Replacement Therapy) using a recombinant soluble form of Phex, the defective protein of XLH patients. 

Read more>>

 

 

Cinacalcet effect on XLH

Kansas City's Children of Mercy Hospital is currently leading a clinical trial to investigate about the potential benefits of the calcimimetic Cinacalcet on children with XLH.

Read more>>

 

 

ED-71

ED-71 from Chugai Pharma is in Phase III trial for osteoporosis in US. Preclinical data inidicates that the compound could be of interest also for XLH.

Read more>>